Prostate cancer Board decisions

The Veteran's prostate cancer residuals are rated at 40 percent from December 1, 2016. The Board has determined that the issue of rating reduction for prostate cancer residuals is remanded.

The Board has restored a 100% rating for prostate cancer, status post radical prostatectomy from May 1, 2016 through October 16, 2019 due to the evidence being at least evenly balanced as to whether there was localized active recurrence and/or metastasis of the cancer.

The Veteran's tension headaches are granted as secondary to his service-connected tinnitus and unspecified anxiety disorder.,Prostate cancer, kidney condition, and bladder condition are all remanded due to the need for additional medical opinions regarding their relationship to exposure at Camp Lejeune.,Back disability is granted as secondary to service-connected left knee degenerative joint disease (left knee disability).,Right hip disability and left hip disability are both remanded as they may be related to service-connected left knee disability.

The Board has decided to remand the claims of service connection for prostate cancer and entitlement to a TDIU due to inadequate medical opinions regarding exposure to harmful chemicals during active duty.

The Veteran's initial compensable evaluation for service-connected residuals of skin cancer affecting the left upper forearm and increased rating in excess of 30 percent for residuals of skin cancer affecting the head, face, and neck have been denied.,Service connection for prostate cancer with urinary incontinence and erectile dysfunction secondary to prostate cancer has been remanded.

The Veteran's prostate cancer, a disease associated with herbicide exposure, is granted for accrued benefits purposes effective April 7, 2004.

The Board has determined that the Veteran was exposed to herbicide agents while serving in Guam, and service connection is granted for prostate cancer. However, further development is needed for basal cell carcinoma as a VA examination is required.

The Board denied the Veteran's claims for service connection for inflatable prosthesis as secondary to prostate cancer and erectile dysfunction, and for diabetes mellitus Type II due to herbicide agent exposure. The claim of service connection for inflatable prosthesis is denied because there is no legal entitlement under the law. The claim of service connection for diabetes mellitus Type II is remanded for a VA examination.

The Veteran's claim for a higher rating for prostate cancer residuals since May 1, 2021 is denied as the evidence does not support an increase in disability beyond what was already assigned.

The Board has granted service connection for Type II diabetes mellitus, finding it presumptively related to herbicide exposure in Thailand. Service connection was not established for prostate cancer due to lack of evidence.

The Board has remanded the case due to insufficient opinion regarding whether the urinary disability is proximately due or aggravated by the service-connected psychiatric disorder. The Veteran's prostate cancer and gastrointestinal disability issues were previously addressed.

The Board has remanded several claims for further development, including obtaining inpatient treatment records and VA treatment records from prior to April 10, 2009. The Veteran's vocational rehabilitation counseling folder is also being sought.

The Board denied service connection for prostate cancer, finding no evidence of herbicide exposure and noting the lack of a direct relationship to service. The Veteran's strong family history was considered more significant than any in-service condition.

The Veteran's service connection claim for prostate cancer is granted due to exposure to herbicides at Don Muang RTAFB during his Vietnam-era service.

The Board has granted earlier effective dates for erectile dysfunction and special monthly compensation based on loss of use of a creative organ. However, the case is remanded to clarify the duration of prostate cancer treatment (brachytherapy or radical prostatectomy) and assign appropriate ratings.

The Veteran's prostate cancer is presumed to be due to in-service exposure to an herbicide agent, specifically Agent Orange. Service connection for this condition has been granted.

The Board has remanded the Veteran's claims for service connection due to inadequate opinions in previous examinations. The claims are now pending and need further review by a VA examiner.

The Board has remanded the case due to insufficient information regarding exposure to herbicide agents or hazardous chemicals during active service. The Veteran's prostate cancer is being reviewed again with new evidence.

The Board has remanded the cases for further development due to a lack of an independent medical opinion and issues related to service connection.

The Board has granted a reduction in the disability rating for prostate cancer from 100% to 60%, effective February 1, 2018. The Veteran's treatment was completed on June 10, 2015, and he is currently rated based on residuals of voiding dysfunction.